Gilead Sciences
GILD
#134
Rank
C$230.22 B
Marketcap
C$185.67
Share price
1.80%
Change (1 day)
22.38%
Change (1 year)

Gilead Sciences (GILD) - P/B ratio

P/B ratio as of August 2026 : 7.08

According to Gilead Sciences's latest financial reports the company has a price-to-book ratio of 5.57901.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Gilead Sciences - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-316.679.47%
2024-12-316.0937.34%
2023-12-314.44-12.6%
2022-12-315.0817.45%
2021-12-314.327.85%
2020-12-314.0110.35%
2019-12-313.63-2.47%
2018-12-313.72-18.42%
2017-12-314.56-6.31%
2016-12-314.87-35.28%
2015-12-317.53-15.71%
2014-12-318.93-8.96%
2013-12-319.8167.83%
2012-12-315.8530.58%
2011-12-314.48-5.7%
2010-12-314.75-20.67%
2009-12-315.98-42.6%
2008-12-3110.4-12.16%
2007-12-3111.9-25.91%
2006-12-3116.0100.72%
2005-12-317.98-4.91%
2004-12-318.39-32.26%
2003-12-3112.45.38%
2002-12-3111.8

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.61 7.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.67-76.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-65.4-1,023.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
33.7 375.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
23.9 238.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.63-76.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
10.7 50.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
6.45-8.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6.88-2.75%๐Ÿ‡บ๐Ÿ‡ธ USA